The effect of Transcutaneous Electrical Nerve (TENS) on the restless leg syndrome (RLS)

Phase 3

Recruiting

• Conditions: Restless Legs Syndrome.; Restless legs syndrome; G25.81

• Registration Number: IRCT20191217045764N2
• Lead Sponsor: Esfarayen University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

People over 35 years old
Restless leg syndrome based on patient self-report
Restless leg syndrome based on a doctor's diagnosis
in the final step, score higher than 4 based on the standard questionnaire

Exclusion Criteria

History of neurological disease other than Restless Legs Syndrome
Presence of vascular diseases other than restless legs syndrome according to the doctor's opinion
Neuromuscular Disorders (Technique Problem)
Experience the crisis over the past 3 months
Patient's unwillingness to cooperate in design
Severe stress to the individual or family over the past two weeks (death of a family member, ...)
Intensification of RLS
Use of antispasmodics over the past two weeks
Use of anticonvulsants in the past two weeks
Use of antidepressants over the past two weeks
Use of sedatives over the past two weeks
Using herbal remedies or any non-pharmacological treatments for treating restless legs syndrome over the past two weeks

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Severity of restless leg syndrome. Timepoint: Before the start of the first stage intervention, before the start of the second stage intervention, before the start of the third stage intervention, the day after the third stage intervention. Method of measurement: Using the International Restless Legs Syndrome Study Group (IRLSS) questionnaire.